Dr. Jenni Li joins GRACE as guest faculty to provide updated information to our Mandarin Lung Cancer Video Library, for our mandarin speaking...
Dr. Jenny Li joins GRACE as guest faculty to provide updated information to our Mandarin Lung Cancer Video Library, for our mandarin speaking...
We are pleased to offer additions to our Lung Cancer Video Library for our Spanish speaking community. Para estos videos adicionales a nuestra...
We are pleased to offer additions to our Lung Cancer Video Library for our Spanish speaking community. Para estos videos adicionales a nuestra...
We are pleased to offer additions to our Lung Cancer Video Library for our Spanish speaking community. Para estos videos adicionales a nuestra...
Dr. Jonathan Goldman joins GRACE to explain why carboplatin, pemetrexed and pembrolizumab has become his new go-to regimen for first-line non-squamous NSCLC treatment.
Over the next few days, about 30,000 oncologists and other cancer care professionals, along with a growing number of patient advocates, are converging...
The FDA just approved a new therapy for the approximately 4% of patients with NSCLC who have the molecular marker known as an ALK rearrangement. The...
GRACE is excited to continue to build the faculty and agenda for the upcoming Targeted Therapies Patient Forum, September 16, 2017. See more information about our presenters in Speaker Highlights - today we introduce John Cherol, EGFR patient.
You may have noticed some frustrating server issues with GRACE these past few days. Our true apologies – we are working diligently with our provider...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.